Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FGF21 promotes ischaemic angiogenesis and endothelial progenitor cells function under diabetic conditions in an AMPK/NAD+-dependent manner.
Dai Q, Fan X, Meng X, Sun S, Su Y, Ling X, Chen X, Wang K, Dai X, Zhang C, Da S, Zhang G, Gu C, Chen H, He J, Hu H, Yu L, Pan X, Tan Y, Yan X. Dai Q, et al. Among authors: pan x. J Cell Mol Med. 2021 Mar;25(6):3091-3102. doi: 10.1111/jcmm.16369. Epub 2021 Feb 17. J Cell Mol Med. 2021. PMID: 33599110 Free PMC article.
CXCR7 Agonist TC14012 Improves Angiogenic Function of Endothelial Progenitor Cells via Activating Akt/eNOS Pathway and Promotes Ischemic Angiogenesis in Diabetic Limb Ischemia.
Wang K, Sun S, Zhang G, Lu Z, Chen H, Fan X, Gu C, Pan X, Lin Q, Chen O, Cai L, Dai X, Wang X, Lu C, Yan X, Tan Y. Wang K, et al. Among authors: pan x. Cardiovasc Drugs Ther. 2023 Oct;37(5):849-863. doi: 10.1007/s10557-022-07337-9. Epub 2022 Apr 26. Cardiovasc Drugs Ther. 2023. PMID: 35471717 Free PMC article.
Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial.
Ji H, Zhao X, Chen X, Fang H, Gao H, Wei G, Zhang M, Kuang H, Yang B, Cai X, Su Y, Piao C, Zhao S, Li L, Sun W, Xu T, Xu Q, Fan Y, Ye J, Yao C, Shang M, Song G, Chen L, Zheng Q, Xiao X, Yan L, Lian F, Tong X, Jia Z; FOCUS Trial Committees and Investigators. Ji H, et al. JAMA Intern Med. 2024 Jun 3. doi: 10.1001/jamainternmed.2024.1190. Online ahead of print. JAMA Intern Med. 2024. PMID: 38829648
Erratum: Author correction to 'FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis' [Acta Pharm Sin B 14 (2024) 1605-1623].
Huang Z, Pan T, Xu L, Shi L, Ma X, Zhou L, Wang L, Wang J, Zhu G, Chen D, Song L, Pan X, Wang X, Li X, Luo Y, Chen Y. Huang Z, et al. Among authors: pan x. Acta Pharm Sin B. 2024 Jun;14(6):2791-2793. doi: 10.1016/j.apsb.2024.04.008. Epub 2024 Apr 9. Acta Pharm Sin B. 2024. PMID: 38828151 Free PMC article.
12,020 results
You have reached the last available page of results. Please see the User Guide for more information.